about
AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 traffickingIncidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysisAcne and Telomere Length: A New Spectrum Between Senescence and Apoptosis PathwaysGenome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanismsA systematic review of the literature on the treatment of pityriasis rubra pilaris type 1 with TNF-antagonists.Psoriasis and its managementDiagnostic accuracy of noninvasive markers of liver fibrosis in patients with psoriasis taking methotrexate: a systematic review and meta-analysis.Psoriasis and cardiometabolic traits: modest association but distinct genetic architectures.Risk of Serious Infections in Patients with Psoriasis on Biologic Therapies: A Systematic Review and Meta-Analysis.AP1S3 Mutations Cause Skin Autoinflammation by Disrupting Keratinocyte Autophagy and Up-Regulating IL-36 ProductionCharacterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis.Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the literature.Predicting treatment response in psoriasis using serum levels of adalimumab and etanercept: a single-centre, cohort study.Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies.Risk of Cancer in Patients with Psoriasis on Biologic Therapies: A Systematic Review.Diagnosing liver fibrosis: a narrative review of current literature for dermatologists.Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis.Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register.Biological therapies for the treatment of severe psoriasis in patients with previous exposure to biological therapy: a cost-effectiveness analysis.British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017.Exposure to biologic therapies during conception and pregnancy: a systematic review.A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis.Screening for anxiety and depression in people with psoriasis: a cross-sectional study in a tertiary referral setting.Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis.Cell trafficking and role of adhesion molecules in psoriasis.British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016.Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris.Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).Development and testing of new candidate psoriatic arthritis screening questionnaires combining optimal questions from existing tools.Genome-wide association study identifies three novel susceptibility loci for severe Acne vulgaris.Psoriasis and cardiovascular disease: where is the risk?The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics.Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis.Loss of IL36RN function does not confer susceptibility to psoriasis vulgaris.Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypes.0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.Does topical tacrolimus induce lentigines in children with atopic dermatitis? A report of three cases.Genome-wide Comparative Analysis of Atopic Dermatitis and Psoriasis Gives Insight into Opposing Genetic Mechanisms.New blisters in a patient treated for Stevens-Johnson syndrome/toxic epidermal necrolysis.A multicenter study of the pharmacokinetics of tacrolimus ointment after first and repeated application to children with atopic dermatitis.
P50
Q24296788-CFE1F936-7B09-4B1B-A3C8-4147419AA7F9Q27007133-E7FD152F-C0BC-4B95-9000-4B7758AFF322Q28005562-126260BF-BD98-46CE-8FA0-D758B6128903Q28385664-8E66DE01-904F-4FCE-B527-1B064C0E7490Q34156074-D954C6F8-EB20-4279-AB3B-805956A36710Q34997840-4271C5E7-4334-47F1-A4B3-5496C44B7284Q35109287-262B3120-90E1-4D1D-B23C-2627BA3043B6Q35470124-A8845B48-E734-4BDD-9687-288BE5FCB339Q37098500-9FF38364-AB4B-4E7B-A538-38FE2D6E3632Q37351626-C5FCB3FF-EEF8-4274-8ADB-253B349F3424Q37652760-48837869-D3B5-422A-BEAB-40C30EC14B44Q37977994-A0666CA7-76CC-4728-A1C4-C2C172B09719Q38095548-F77164FB-0515-4838-91CB-E47F7A00996CQ38194199-5B968A3B-357C-491D-A81A-49C287F8EA4CQ38672588-30D2B0AF-31BD-4F0E-9474-937C351B54ADQ38780434-399D64F4-4EA7-4FFA-B943-F6F959F232B7Q38812025-11EBC26D-1101-4142-A0EE-69080618541EQ39004998-0ACAD161-A1AF-4DFA-951C-81C9CB9CCC51Q39070719-C230BCCC-B91E-4C75-9408-0635A4177DFBQ39312849-1F4E0CC2-9FE6-4A78-8E01-070F309F3374Q39441592-436E809F-1968-47EA-922B-0BC2F3FEEC81Q39561305-99AA4BDE-DA88-4EE0-AAF5-C19F15AC8E7EQ39642015-1B66784E-0BAA-4D3B-91D0-B39FA8ED283EQ40361784-BE060FB9-8CE4-4B22-9487-B6240AE5DA89Q40544686-A488F1B5-AE31-4799-80EE-7CAFFCCE7F20Q40590985-CD36D7B0-8C11-4950-9C2C-E8B89C882A85Q40704590-78AA555C-F4BD-499F-A181-6F6CDEDC60A2Q40859779-E31FA979-5B23-4DFB-BAC0-B557886D3C76Q43422024-4950B4EF-AC67-414F-A02B-7A28FC91FAFDQ43751482-44FE058B-D1F1-4A26-B4C1-5FDDEF7B3947Q43841534-7336DAAC-24AB-41DF-9488-2F7CDDA7411BQ43854579-6492C52C-BE94-458A-94BB-F594A929953BQ43920215-49EAE02C-825B-44FA-83BF-38DAF07A626EQ44290809-48A43EEC-DDA5-41A0-8B7D-A9F989BC03DCQ44409945-8A86E516-23BE-4184-BE3C-2CE50DCA4797Q44804913-B34A8D1A-80E2-4964-B568-4D09695695E4Q45228837-8B21DD5A-684D-48F4-BC34-E35B7A919806Q46169094-DFC560BF-3C48-45C3-A0C0-D01B7E58268BQ46403201-54B86C62-C70E-4CD6-9600-030B1999C47EQ46427077-4F6F4D5E-B9EB-4F3D-884A-0BB73A70168E
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Catherine H Smith
@ast
Catherine H Smith
@en
Catherine H Smith
@es
Catherine H Smith
@nl
Catherine H Smith
@sl
type
label
Catherine H Smith
@ast
Catherine H Smith
@en
Catherine H Smith
@es
Catherine H Smith
@nl
Catherine H Smith
@sl
altLabel
Catherine Smith
@en
prefLabel
Catherine H Smith
@ast
Catherine H Smith
@en
Catherine H Smith
@es
Catherine H Smith
@nl
Catherine H Smith
@sl
P1053
G-5268-2012
P106
P21
P31
P3829
P496
0000-0001-9918-1144
P569
2000-01-01T00:00:00Z